Key Insights

Highlights

Treatment Research

4 treatments under study, led by Botanical Extract 125mg

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07085819Not ApplicableRecruitingPrimary

Sleep Promoting Properties of a Botanical Extract in a Population Complaining From Non-Restorative Sleep (NRS)

Showing all 1 trials

Research Network

Common Treatments

  • Botanical Extract 125mg1
  • Botanical Extract 250mg1
  • Botanical Extract 500mg1
  • Pacebo1

Active Sponsors

  • Atlantia Food Clinical Trials1
  • Kerry Group P.L.C1

Top Investigators

Related Conditions

  • Sleep Disorder Disorder1

Activity Timeline